Edith Peterson Mitchell, MD, a leading researcher, medical oncologist and proponent of combined modality treatment, has been chosen as the 2017 American Society for Radiation Oncology (ASTRO) Honorary Member.
Today, Risk Analysis, an International Journal, published Part 2 of a special issue focused on modeling global measles and rubella health and financial costs (following the publication of Part I in July 2016). The special issue outlines the tools used by the WHO and the US Centers for Disease Control and Prevention (CDC) to assess performance of measles control activities, evaluate progress toward regional measles elimination, and identify high risk areas to better allocate available resources to meet national and regional elimination goals.
When Microsoft was presented with the P3 Impact Award in 2015 by the University of Virginia Darden School of Business, Concordia and U.S. State Department, the public-private effort to bring broadband internet to remote areas around the world was just beginning to make an impact.
Darden Professor Jeremy Hutchison-Krupat, whose research focuses on the effective execution of a firm’s innovation strategy, takes a deep look at questions such as How does a big company make good decisions to launch new products that might fatten up the bottom line and keep it innovative and growing? How can project managers get around the typical information imbalance existing in all large companies to make the most informed decisions on where to plunk their money and manpower?
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs.
It’s that time of year again: parents are beginning to buy their children school supplies for the upcoming school year. But what parents may not know is that one particular item is sending thousands of children to their doctors' offices every year—backpacks.
It lives in boiling acid that dissolves flesh and bone. Now scientists have unlocked the secrets of the indestructible virus, potentially allowing them to harness its remarkable properties to create super-durable materials and better treat disease.
The Society for Risk Analysis (SRA) invites the submission of abstracts for presentations at the Fifth World Congress on Risk to be held in Cape Town, Africa, May 6-8, 2019.
The Society for Risk Analysis (SRA) inducted Kenneth Arrow to the Pantheon of Risk Analysis. The Pantheon recognizes luminaries and visionaries in risk analysis and serves to illustrate how the field contributes to the advancement of knowledge and public good.
The members of the American Society for Radiation Oncology (ASTRO) have elected a new President-elect, Health Policy Council Vice-chair and Science Council Vice-chair to ASTRO’s Board of Directors and three members to serve on the medical society’s Nominating Committee.
Michael Sargent (GEMBA '17) put his Darden education on hold when called to redeploy to Afghanistan, where his heroics earned him the Silver Star.
The American College of Radiology (ACR) collaborated with professional medical societies to update guidance to promote safe and effective diagnostic and therapeutic radiology use.
The AAPS Journal, AAPS PharmSciTech and Pharmaceutical Research receive impactful measurement numbers in new report
The University of Virginia Darden School of Business announces several new leadership appointments to its MBA program team in preparation for the 2017–18 academic year and in support of its continuous efforts to enhance Darden’s renowned educational experience.
The winner of the American Society for Radiation Oncology’s (ASTRO’s) 2017 Survivor Circle Award is many things—a former pro baseball player, a retired UPS driver, a family man and, yes, a current cancer patient.
As an increasingly popular approach to business innovation, the crux of design thinking is that it embraces both creativity and analytical thinking to solve problems; two sides of the design thinking coin, both are essential to the design thinking process.
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer. The updated Proton Beam Therapy Model Policy provides guidance to payers on clinical indications that are appropriate for treatment with proton therapy and should be covered by health insurance.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right